Education
About Us
Working with TipRanks
Follow Us
Ispecimen Inc (ISPC)
:ISPC
ISPC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.00 - $11.80
Previous CloseN/A
Volume25.67K
Average Volume (3M)48.86K
Market Cap
$2.65M
Enterprise Value-$2.98M
Total Cash (Recent Filing)$1.88M
Total Debt (Recent Filing)$312.17K
Price to Earnings (P/E)―
Beta0.03
Next Earnings
Aug 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.71
Shares Outstanding2,496,858
10 Day Avg. Volume52,921
30 Day Avg. Volume48,864
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.60
Price to Sales (P/S)0.00
P/FCF Ratio-1.35
Enterprise Value/Market Cap-1.13
Enterprise Value/Revenue-0.08
Enterprise Value/Gross Profit-1.07
Enterprise Value/Ebitda0.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
iSpecimen News
PremiumCompany Announcements
iSpecimen Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
iSpecimen Delays 10-Q Filing for Q1 2025
PremiumCompany Announcements
iSpecimen Delays Yearly Report Due to Auditor Change
PremiumCompany Announcements
iSpecimen Announces Key Leadership Appointments
PremiumCompany Announcements
iSpecimen Strengthens Leadership and Expands Cancer Research Focus
PremiumCompany Announcements
iSpecimen Appoints Robert Lim as New CEO
PremiumCompany Announcements
iSpecimen Inc. Reports Earnings Amid Financial ChallengesOptions Prices
Currently, No data available
---
Ownership Overview
53.38%
Insiders
1.21% Mutual Funds
0.87% Other Institutional Investors
97.85% Public Companies and Individual Investors
ISPC FAQ
What was Ispecimen Inc’s price range in the past 12 months?
Ispecimen Inc lowest stock price was $1.00 and its highest was $11.80 in the past 12 months.
What is Ispecimen Inc’s market cap?
Ispecimen Inc’s market cap is $2.65M.
When is Ispecimen Inc’s upcoming earnings report date?
Ispecimen Inc’s upcoming earnings report date is Aug 12, 2025 which is in 57 days.
How were Ispecimen Inc’s earnings last quarter?
Ispecimen Inc released its earnings results on May 13, 2025. The company reported -$0.714 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.714.
Is Ispecimen Inc overvalued?
According to Wall Street analysts Ispecimen Inc’s price is currently Overvalued.
Does Ispecimen Inc pay dividends?
Ispecimen Inc does not currently pay dividends.
What is Ispecimen Inc’s EPS estimate?
Ispecimen Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ispecimen Inc have?
Ispecimen Inc has 2,496,858 shares outstanding.
What happened to Ispecimen Inc’s price movement after its last earnings report?
Ispecimen Inc reported an EPS of -$0.714 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.855%.
Which hedge fund is a major shareholder of Ispecimen Inc?
Currently, no hedge funds are holding shares in ISPC
Company Description
Ispecimen Inc
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.